Arianna Bertolani

Bertolani Arianna is a Junior Lecturer of Health Policy at SDA Bocconi School of Management.

She has collaborated in the implementation and realization of research and education projects in the field of drug policies, market access and economic evaluations. As a member of the Pharmaceutical Observatory (OSFAR) of CeRGAS (Center for Research on Health and Social Care Management) – SDA Bocconi, she contributes every year to the drafting of a report which photographs the national and international situation regarding pharmaceutical spending and policy.

Her research is mainly focused on the analysis of pharmaceutical spending (public and private), on the evaluation of the main national and international policies related to the pharmaceutical context, on the analysis of the costs of diseases and on the economic evaluations of health technologies.

She is the author of several chapters related to health and pharmaceutical spending published in the OASI (Observatory on Healthcare Organizations and Policies in Italy) Report (Osservatorio sulle Aziende e sul Sistema Sanitario Italiano) and some articles published in major international and national journals, such as Clinical Therapeutics and Global & Regional Health Technology Assessment (GRHTA). The most recent include: «Implementation of Value-based Pricing for Medicines (Clinical Therapeutics 2020)» and «The hospitalization burden of influenza: just the tip of the iceberg? Influenza-driven admission to hospitals: the Italian case. The hospitalization burden of influenza in Italy (GRHTA 2018)».

After graduating in Pharmaceutical Biotechnology at the Università degli Studi di Milano and obtaining a Ph.D. in Chemical Engineering and Industrial Chemistry at the Politecnico di Milano, Arianna earned a Master in Healthcare Management (MiMS) at SDA Bocconi. Currently, she is a Junior Lecturer and works within the Government, Health and Not for Profit division (GHNP) of SDA Bocconi.